Table 1.

Clinical samples and SARS-CoV-2 rRT-PCR assay in this study.

Patient	ID	Collection date	Day	Sample type	rRT-PCR (Ct, E/RdRP)
Patient 1	1-S1	03-Sep-2020	1	Sputum	12.92/14.97
	1-S2	03-Sep-2020	1	Nasopharyngeal swab	14.88/17.03
	1-S3	17-Sep-2020	15	Sputum	16.6/18.32
	1-S5	24-Sep-2020	22	Sputum	17.03/18.32
	1-S6	24-Sep-2020	22	Nasopharyngeal swab	17.88/19.37
	1-S7	12-Oct-2020	40	Nasopharyngeal swab	16.14/17.3
	1-S8	25-Oct-2020	53	Sputum	22.07/23.46
	1-S9	25-Oct-2020	53	Nasopharyngeal swab	16.41/17.06
	1-S12	12-Nov-2020	71	Sputum	20.12/21.26
	1-S17	05-Feb-2021	156	Sputum	26.21/26.04
Patient 2	2-S1	20-Nov-2020	0	Nasopharyngeal swab	12.22/11.55
	2-S2	02-Dec-2020	12	Nasopharyngeal swab	16.51/15.86
	2-R1	02-Dec-2020	12	Saliva	27.93/28.27
	2-S4	02-Dec-2020	12	Stool	24.83/25.17
	2-R4	07-Dec-2020	17	throat swab	18.93/18.23
	2-S6	09-Dec-2020	19	Nasopharyngeal swab	16.67/16.92
	2-S7	09-Dec-2020	19	Saliva	21.15/21.15
	2-S8	09-Dec-2020	19	Stool	20.64/21.83
	2-R2	09-Dec-2020	19	Urine	30.19/30.62
	2-S10	19-Dec-2020	29	Nasopharyngeal swab	20.05/19.24
	2-S11	28-Dec-2020	38	Nasopharyngeal swab	14.76/14.47
	2-S12	11-Jan-2021	52	Nasopharyngeal swab	21.55/20.44
	2-R8	13-Jan-2021	54	Saliva	24.05/24.09
	2-R10	18-Jan-2021	59	Nasopharyngeal swab	25.91/25.23
	2-R11	22-Jan-2021	63	Nasopharyngeal swab	23.96/23.75
	2-R12	26-Jan-2021	67	Nasopharyngeal swab	25.23/24.65
Patient 2’ mother	2-R3	11-Jan-2021		Nasopharyngeal swab	20.56/26.74

Day 0 was the day of clinical diagnosis. Cycle threshold (Ct) values <40 were defined as positive. Ct, Cycle threshold; rRT-PCR, real-time reverse-transcription PCR.